{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T21:13:20Z","timestamp":1694121200821},"reference-count":17,"publisher":"Galenos Yayinevi","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tjh"],"published-print":{"date-parts":[[2023,8,31]]},"DOI":"10.4274\/tjh.galenos.2023.2023.0116","type":"journal-article","created":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T13:39:27Z","timestamp":1693575567000},"page":"183-186","source":"Crossref","is-referenced-by-count":0,"title":["Identifying Risk Factors and Improving Preventive Strategies for Febrile Neutropenia in Children with Leukemia Receiving Ciprofloxacin Prophylaxis"],"prefix":"10.4274","volume":"40","author":[{"given":"Z\u00fchre","family":"Kaya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nurettin","family":"Al\u0131c\u0131","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serap","family":"K\u0131rk\u0131z","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00dclker","family":"Ko\u00e7ak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2811","published-online":{"date-parts":[[2023,8,31]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1093\/cid\/ciz1082","article-title":"Guideline for Antibacterial Prophylaxis Administration in Pediatric Cancer and Hematopoietic Stem Cell Transplantation","volume":"71","author":"Lehrnbecher","year":"2020","unstructured":"1. Lehrnbecher T, Fisher BT, Phillips B, Alexander S, Ammann RA, Beauchemin M, Carlesse F, Castagnola E, Davis BL, Dupuis LL, Egan G, Groll AH, Haeusler GM, Santolaya M, Steinbach WJ, van de Wetering M, Wolf J, Cabral S, Robinson PD, Sung L. Guideline for Antibacterial Prophylaxis Administration in Pediatric Cancer and Hematopoietic Stem Cell Transplantation. Clin Infect Dis 2020;71:226-236.","journal-title":"Clin Infect Dis"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1001\/jama.2018.12512","article-title":"Effect of levofloxacin prophylaxis on bacteremia in children with acute leukemia or undergoing hematopoietic stem cell transplantation: a randomized clinical trial","volume":"320","author":"Alexander","year":"2018","unstructured":"2. Alexander S, Fisher BT, Gaur AH, Dvorak CC, Villa Luna D, Dang H, Chen L, Green M, Nieder ML, Fisher B, Bailey LC, Wiernikowski J, Sung L; Children's Oncology Group. Effect of levofloxacin prophylaxis on bacteremia in children with acute leukemia or undergoing hematopoietic stem cell transplantation: a randomized clinical trial. JAMA 2018;320:995-1004.","journal-title":"JAMA"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/JBM.S33906","article-title":"Randomized double blind trial of ciprofloxacin prophylaxis during induction treatment in childhood acute lymphoblastic leukemia in the WK-ALL protocol in Indonesia","volume":"4","author":"Widjajanto","year":"2013","unstructured":"3. Widjajanto PH, Sumadiono S, Cloos J, Purwanto I, Sutaryo S, Veerman AJ. Randomized double blind trial of ciprofloxacin prophylaxis during induction treatment in childhood acute lymphoblastic leukemia in the WK-ALL protocol in Indonesia. J Blood Med 2013;4:1-9.","journal-title":"J Blood Med"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4. Laoprasopwattana K, Khwanna T, Suwankeeree P, Sujjanunt T, Tunyapanit W, Chelae S. Ciprofloxacin reduces the occurrence of fever in children with acute leukemia who develop neutropenia during chemotherapy. Pediatr Infect Dis J 2013;32:e94-98.","DOI":"10.1097\/INF.0b013e3182793610"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.3906\/sag-1901-90","article-title":"Risk factors for bacteremia in children with febrile neutropenia","volume":"49","author":"Kara","year":"2019","unstructured":"5. Kara SS, Tezer H, Polat M, Cura Yayla BC, Bedir Demirda\u011f T, Okur A, Fettah A, Kan\u0131k Y\u00fcksek S, Tap\u0131s\u0131z A, Kaya Z, \u00d6zbek N, Yenicesu \u0130, Yaral\u0131 N, Ko\u00e7ak \u00dc. Risk factors for bacteremia in children with febrile neutropenia. Turk J Med Sci 2019;49:1198-1205.","journal-title":"Turk J Med Sci"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.7812\/TPP\/17-141","article-title":"Prevalence and safety of intravenous immunoglobulin administration during maintenance chemotherapy in children with acute lymphoblastic leukemia in first complete remission: a health maintenance organization perspective","volume":"22","author":"Van Winkle","year":"2018","unstructured":"6. Van Winkle P, Burchette R, Kim R, Raghunathan R, Qureshi N. Prevalence and safety of intravenous immunoglobulin administration during maintenance chemotherapy in children with acute lymphoblastic leukemia in first complete remission: a health maintenance organization perspective. Perm J 2018;22:17-141.","journal-title":"Perm J"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"3350","DOI":"10.1200\/JCO.2004.09.106","article-title":"Prophylactic granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor decrease febrile neutropenia after chemotherapy in children with cancer: a meta-analysis of randomized controlled trials","volume":"22","author":"Sung","year":"2004","unstructured":"7. Sung L, Nathan PC, Lange B, Beyene J, Buchanan GR. Prophylactic granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor decrease febrile neutropenia after chemotherapy in children with cancer: a meta-analysis of randomized controlled trials. J Clin Oncol 2004;22:3350-3356.","journal-title":"J Clin Oncol"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8. Alali M, David MZ, Ham SA, Danziger-Isakov L, Pisano J. Febrile neutropenia syndromes in children: risk factors and outcomes of primary, prolonged, and recurrent fever. J Pediatr Hematol Oncol 2021;43:e962-e971.","DOI":"10.1097\/MPH.0000000000002221"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"130","DOI":"10.3109\/08880018.2011.629859","article-title":"ALL-BFM 95 treatment in Turkish children with acute lymphoblastic leukemia--experience of a single center","volume":"29","author":"Kocak","year":"2012","unstructured":"9. Kocak U, Gursel T, Kaya Z, Aral YZ, Albayrak M, Keskin EY, Belen B, Is\u0131k M, Oner N. ALL-BFM 95 treatment in Turkish children with acute lymphoblastic leukemia--experience of a single center. Pediatr Hematol Oncol 2012;29:130-140.","journal-title":"Pediatr Hematol Oncol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1038\/sj.leu.2403924","article-title":"Treatment strategy and long-term results in pediatric patients treated in consecutive UK AML trials","volume":"19","author":"Gibson","year":"2005","unstructured":"10. Gibson BE, Wheatley K, Hann IM, Stevens RF, Webb D, Hills RK, De Graaf SS, Harrison CJ. Treatment strategy and long-term results in pediatric patients treated in consecutive UK AML trials. Leukemia 2005;19:2130-2138.","journal-title":"Leukemia"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1086\/522533","article-title":"A prospective study on the epidemiology of febrile episodes during chemotherapy-induced neutropenia in children with cancer or after hemopoietic stem cell transplantation","volume":"45","author":"Castagnola","year":"2007","unstructured":"11. Castagnola E, Fontana V, Caviglia I, Caruso S, Faraci M, Fioredda F, Garr\u00e8 ML, Moroni C, Conte M, Losurdo G, Scuderi F, Bandettini R, Tom\u00e0 P, Viscoli C, Haupt R. A prospective study on the epidemiology of febrile episodes during chemotherapy-induced neutropenia in children with cancer or after hemopoietic stem cell transplantation. Clin Infect Dis 2007;45:1296-1304.","journal-title":"Clin Infect Dis"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12. Lehrnbecher T, Averbuch D, Castagnola E, Cesaro S, Ammann RA, Garcia-Vidal C, Kanerva J, Lanternier F, Mesini A, Mikulska M, Pana D, Ritz N, Slavin M, Styczynski J, Warris A, Groll AH; 8th European Conference on Infections in Leukaemia. 8th European Conference on Infections in Leukaemia: 2020 guidelines for the use of antibiotics in paediatric patients with cancer or post-hematopoietic cell transplantation. Lancet Oncol 2021;22:e270-e280.","DOI":"10.1016\/S1470-2045(20)30725-7"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"417","DOI":"10.15446\/revfacmed.v64n3.53961","article-title":"Interim analysis in a referral center in Colombia","volume":"64","author":"Trujillo","year":"2016","unstructured":"13. Trujillo AM, Linares A, Sarmiento IC. Intensive chemotherapy in children with acute lymphoblastic leukemia. Interim analysis in a referral center in Colombia. Rev Fac Med 2016;64:417-425.","journal-title":"Rev Fac Med"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1179\/1973947812Y.0000000002","article-title":"Risk of repeated febrile episodes during chemotherapy-induced granulocytopenia in children with cancer: a prospective single-center study","volume":"24","author":"Bagnasco","year":"2012","unstructured":"14. Bagnasco F, Haupt R, Fontana V, Valsecchi MG, Rebora P, Caviglia I, Caruso S, Castagnola E. Risk of repeated febrile episodes during chemotherapy-induced granulocytopenia in children with cancer: a prospective single-center study. J Chemother 2012;24:155-160.","journal-title":"J Chemother"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1200\/JCO.2009.25.8988","article-title":"Predicting adverse events in children with fever and chemotherapy-induced neutropenia: the prospective multicenter SPOG 2003 FN study","volume":"28","author":"Ammann","year":"2010","unstructured":"15. Ammann RA, Bodmer N, Hirt A, Niggli FK, Nadal D, Simon A, Ozsahin H, Kontny U, K\u00fchne T, Popovic MB, L\u00fcthy AR, Aebi C. Predicting adverse events in children with fever and chemotherapy-induced neutropenia: the prospective multicenter SPOG 2003 FN study. J Clin Oncol 2010;28:2008-2014.","journal-title":"J Clin Oncol"},{"key":"ref15","unstructured":"16. Al\u0131c\u0131 N, Kaya Z, Kirkiz S, Ay\u00e7a \u015eahin E, Ko\u00e7ak U. Side effects and resistance to ciprofloxacin prophylaxis and the frequency of bacterial infections during febrile neutropenia in children with leukemia: a single center experience. Trends in Cancer Research 2022;17:21-33."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s12098-012-0925-3","article-title":"Evaluation of predictors of adverse outcome in febrile neutropenic episodes in pediatric oncology patients","volume":"80","author":"Bothra","year":"2013","unstructured":"17. Bothra M, Seth R, Kapil A, Dwivedi SN, Bhatnagar S, Xess I. Evaluation of predictors of adverse outcome in febrile neutropenic episodes in pediatric oncology patients. Indian J Pediatr 2013;80:297-302.","journal-title":"Indian J Pediatr"}],"container-title":["Turkish Journal of Hematology"],"original-title":[],"deposited":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T06:51:17Z","timestamp":1693810277000},"score":1,"resource":{"primary":{"URL":"https:\/\/jag.journalagent.com\/z4\/download_fulltext.asp?pdir=tjh&plng=eng&un=TJH-73444"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,31]]},"references-count":17,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,8,31]]},"published-print":{"date-parts":[[2023,8,31]]}},"URL":"https:\/\/doi.org\/10.4274\/tjh.galenos.2023.2023.0116","relation":{},"ISSN":["1300-7777","1308-5263"],"issn-type":[{"value":"1300-7777","type":"print"},{"value":"1308-5263","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,31]]}}}